Halozyme Therapeutics, Inc. (HALO)

71.94 +0.22 (+0.31%) USD  |  NASDAQ  |  Jan 22, 09:40
More

Halozyme Therapeutics Hold Recommendations

Hold Recommendations Chart

View Hold Recommendations for HALO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Hold Recommendations Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Hold Recommendations Range, Past 5 Years

View Hold Recommendations Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Hold Recommendations Benchmarks

View Hold Recommendations Benchmarks
Start Trial
Johnson & Johnson Upgrade
Merck & Co., Inc. Upgrade
AIM ImmunoTech, Inc. Upgrade
Stryker Corp. Upgrade
Skye Bioscience, Inc. Upgrade